Jack Khattar

Mr. Jack A. Khattar is a President, Treasurer & Director at SAGE Therapeutics, Inc., a President, Secretary, Treasurer & Director at Adamas Pharmaceuticals LLC, a Chairman at Cognition Therapeutics, Inc., a President, CEO, Secretary & Director at Supernus Pharmaceuticals, Inc., an Advisor at New Rhein Healthcare Investors and a Chief Executive Officer at Supernus, Inc. He is on the Board of Directors at SAGE Therapeutics, Inc., Adamas Pharmaceuticals LLC and Supernus Pharmaceuticals, Inc. Mr. Khattar was previously employed as a Chairman by scPharmaceuticals, Inc., a President, Chief Executive Officer & Director by Shire Laboratories, Inc., a Member by Shire Pharmaceuticals Group Plc, an Executive Officer by CIMA Labs, Inc., a Principal by Kodak Ltd., a Member by Licensing Executives Society, a Principal by Merck & Co., Inc., and a Principal by Novartis Corp.
He also served on the board at Navitor Pharmaceuticals, Inc., Prevacus, Inc., Rockville Economic Development, Inc. and Navitor Pharmaceuticals, Inc. He received his undergraduate degree from American University of Beirut and an MBA from The Wharton School of the University of Pennsylvania.